Benzinga | Jul 23, 2021 09:23AM EDT

Morgan Stanley Maintains Overweight on Abbott Laboratories, Raises Price Target to $136

Morgan Stanley analyst Cecilia Furlong maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $126 to $136.